Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.690
+0.090 (3.46%)
At close: Jul 21, 2026, 4:00 PM EDT
2.750
+0.060 (2.23%)
After-hours: Jul 21, 2026, 4:04 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $201.12 million as of July 21, 2026. Its market cap has increased by 52.82% in one year.
Market Cap
201.12M
Enterprise Value
99.11M
1-Year Change
52.82%
Ranking
Category
Stock Price
$2.69
ChartMarket Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $201.12M, a decrease of -85.03%. That is a compound annual growth rate of -15.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 188.80M | -46.07% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 201.89M |
| Atrium Therapeutics | 201.16M |
| Codexis | 200.88M |
| Protalix BioTherapeutics | 194.18M |
| Precision BioSciences | 189.90M |
| MediWound | 187.64M |
| Armata Pharmaceuticals | 185.76M |
| Voyager Therapeutics | 184.28M |